Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-07-26
2011-07-26
Berch, Mark L (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S263400, C544S277000
Reexamination Certificate
active
07985754
ABSTRACT:
The present invention provides compounds of formulae Ia and Ib:wherein R1-5, Q, X, Y, Z, p, q, and r are as defined herein. The compounds are potent and selective antagonists of A2Aadenosine receptors (ARs). The invention further includes pharmaceutical compositions containing these compounds and methods of using the same.
REFERENCES:
patent: 2007/0270373 (2007-11-01), Rieger et al.
patent: 2008/0009460 (2008-01-01), Linden et al.
patent: 2008/0027022 (2008-01-01), Linden et al.
patent: 2008/0262001 (2008-10-01), Kranenburg et al.
patent: 2008/0312160 (2008-12-01), Guerrant et al.
patent: 2009/0181920 (2009-07-01), Watkins et al.
patent: 2009/0280059 (2009-11-01), Rieger et al.
Beauglehole Anthony
Rieger Jayson M.
Thompson Robert D.
Berch Mark L
McCarter & English LLP
Trovis Pharmaceuticals, LLC
LandOfFree
Selective antagonists of A 2A adenosine receptors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Selective antagonists of A 2A adenosine receptors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Selective antagonists of A 2A adenosine receptors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2632615